Medema, Marnix H, Alam, Mohammad T., Breitling, Rainer and Takano, Eriko (2011) The future of industrial antibiotic production: from random mutagenesis to synthetic biology. Bioengineered, 2 (4). pp. 230-3. ISSN 1949-1026.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Request Changes to record.

Abstract

Natural products derived from the secondary metabolism of microbes constitute a cornerstone of modern medicine. Engineering bugs to produce these products in high quantities is a major challenge for biotechnology, which has usually been tackled by either one of two strategies: iterative random mutagenesis or rational design. Recently, we analyzed the transcriptome of a Streptomyces clavuligerus strain optimized for production of the β-lactamase inhibitor clavulanic acid by multiple rounds of mutagenesis and selection, and discovered that the observed changes matched surprisingly well with simple changes that have been introduced into these strains by rational engineering. Here, we discuss how in the new field of synthetic biology, random mutagenesis and rational engineering can be implemented complementarily in ways which may enable one to go beyond the status quo that has now been reached by each method independently.

Item Type:	Journal Article
Divisions:	Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Microbiology & Infection
Journal or Publication Title:	Bioengineered
Publisher:	Taylor & Francis
ISSN:	1949-1026
Official Date:	August 2011
Dates:	Date Event August 2011 Published 10 May 2011 Accepted 20 April 2011 Submitted
Volume:	2
Number:	4
Page Range:	pp. 230-3
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item